C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease
- PMID: 12853388
- PMCID: PMC164245
- DOI: 10.1128/cdli.10.4.573-578.2003
C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease
Abstract
Borreliacidal antibodies specific for outer surface protein C (OspC) are induced shortly after infection with Borrelia burgdorferi. In this study, we identified the region of OspC recognized by immunoglobulin M (IgM) and IgG borreliacidal antibodies. Sera from patients with early Lyme disease were screened for borreliacidal activity specific for B. burgdorferi 50772 and OspC antibodies. Seven sera that contained similarly high titers of each response were then chosen randomly and adsorbed with OspC or a truncated OspC (OspC-Dra) containing the 50 amino acids nearest the carboxy terminus. Adsorption with OspC or OspC-Dra completely eliminated the borreliacidal activity in six (86%) of seven sera and significantly decreased the activity in the remaining serum (titer of 10,240 to 1,280). Moreover, OspC antibodies were no longer detected by OspC enzyme-linked immunosorbent assay or in a Western blot that contained native OspC. The findings confirmed that sera from patients with early Lyme disease contain high concentrations of IgM or IgG borreliacidal antibodies that bind a conserved region of OspC.
Figures




Similar articles
-
Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.Clin Diagn Lab Immunol. 2005 Jun;12(6):746-51. doi: 10.1128/CDLI.12.6.746-751.2005. Clin Diagn Lab Immunol. 2005. PMID: 15939749 Free PMC article.
-
Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.Clin Vaccine Immunol. 2008 Jun;15(6):981-5. doi: 10.1128/CVI.00079-08. Epub 2008 Apr 16. Clin Vaccine Immunol. 2008. PMID: 18417666 Free PMC article.
-
Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.FEMS Immunol Med Microbiol. 2000 Sep;29(1):15-21. doi: 10.1111/j.1574-695X.2000.tb01499.x. FEMS Immunol Med Microbiol. 2000. PMID: 10967255
-
Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.J Infect Dis. 1998 Sep;178(3):733-41. doi: 10.1086/515382. J Infect Dis. 1998. PMID: 9728542
-
Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.Int J Med Microbiol. 2002 Jun;291 Suppl 33:141-6. doi: 10.1016/s1438-4221(02)80027-3. Int J Med Microbiol. 2002. PMID: 12141738 Review.
Cited by
-
One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.Clin Vaccine Immunol. 2010 May;17(5):870-4. doi: 10.1128/CVI.00524-09. Epub 2010 Mar 17. Clin Vaccine Immunol. 2010. PMID: 20237200 Free PMC article.
-
[Bilateral reduction in visual acuity with extensive macular edema].Ophthalmologe. 2016 Nov;113(11):952-954. doi: 10.1007/s00347-016-0236-6. Ophthalmologe. 2016. PMID: 27027781 German. No abstract available.
-
Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.Vaccine. 2007 Apr 30;25(17):3419-27. doi: 10.1016/j.vaccine.2006.12.051. Epub 2007 Jan 17. Vaccine. 2007. PMID: 17239505 Free PMC article.
-
Human and Veterinary Vaccines for Lyme Disease.Curr Issues Mol Biol. 2021;42:191-222. doi: 10.21775/cimb.042.191. Epub 2020 Dec 8. Curr Issues Mol Biol. 2021. PMID: 33289681 Free PMC article.
-
Beta2 integrins control the severity of murine Lyme carditis.Infect Immun. 2005 Jun;73(6):3242-50. doi: 10.1128/IAI.73.6.3242-3250.2005. Infect Immun. 2005. PMID: 15908348 Free PMC article.
References
-
- Agger, W. A., K. L. Case, G. L. Bryant, and S. M. Callister. 1991. Lyme disease: clinical features, classification, and epidemiology in the upper Midwest. Medicine 70:83-90. - PubMed
-
- Andrew, S. M., and J. A. Titus. 1997. Purification and fragmentation of antibodies. p. 2.7.1-2.7.12 In J. E. Coligan, A. M. Kruisbeck, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley and Sons, Inc., New York, N.Y.
-
- Andrew, S. M., J. A. Titus, R. Coico, and A. Amin. 1997. Purification of immunoglobulin M and immunoglobulin D, p. 2.9.1-2.9.8 In J. E. Coligan, A. M. Kruisbeck, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley and Sons, Inc., New York, N.Y.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical